Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China · Delayed Price · Currency is CNY 35.70
+1.41 (4.11%)
Apr 15, 2026, 3:04 PM CST
SHE:002422 Revenue
In the year 2025, Sichuan Kelun Pharmaceutical had annual revenue of 18.51B CNY, down -15.13%. Sichuan Kelun Pharmaceutical had revenue of 5.24B in the quarter ending December 31, 2025, with 4.23% growth.
Revenue
18.51B
Revenue Growth
-15.13%
P/S Ratio
3.07
Revenue / Employee
919.81K
Employees
20,127
Market Cap
56.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.51B | -3.30B | -15.13% |
| Dec 31, 2024 | 21.81B | 358.49M | 1.67% |
| Dec 31, 2023 | 21.45B | 2.42B | 12.69% |
| Jan 1, 2023 | 19.04B | 1.76B | 10.19% |
| Jan 1, 2022 | 17.28B | 813.21M | 4.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.96B |
| Zhejiang Int'l Group | 33.54B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yifan Pharmaceutical | 5.22B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 2.81B |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.05B |
| Shanghai InnoStar Bio-tech | 811.33M |
Sichuan Kelun Pharmaceutical News
- 4 months ago - Crescent, Kelun-Biotech Sign Oncology Deal; Crescent To Raise $185 Mln; Stock Up - Nasdaq